Paper32155751
Antimicrobial Activity of a Phage Mixture and a Lactic Acid Bacterium against Staphylococcus aureus from Bovine Mastitis.
Titze I and 1 other. Vet Sci, 2020. Cited by 23 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antimicrobial Activity of a Phage Mixture and a Lactic Acid Bacterium against Staphylococcus aureus from Bovine Mastitis. Papers, record 32155751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32155751
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antimicrobial Activity of a Phage Mixture and a Lactic Acid Bacterium against Staphylococcus aureus from Bovine Mastitis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 5-18 | Steinbeis Research Center Milk Science, Kirchlengern, Germany | PubMed |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24,631,574 | Experimental phage therapy against lethal lung-derived septicemia caused by Staphylococcus aureus in mice. | Microbes Infect | 2014 | https://conductscience.org/library/papers/24631574 | PubMed |
| 2 | 22,365,211 | Manageable risk factors associated with the lactational incidence, elimination, and prevalence of Staphylococcus aureus intramammary infections in dairy cows. | J Dairy Sci | 2012 | https://conductscience.org/library/papers/22365211 | PubMed |
| 3 | 5,318,444 | Host-controlled modification of bacteriophage. | Annu Rev Microbiol | 1965 | https://conductscience.org/library/papers/5318444 | PubMed |
| 4 | 19,627,589 | The use of antibiotics to improve phage detection and enumeration by the double-layer agar technique. | BMC Microbiol | 2009 | https://conductscience.org/library/papers/19627589 | PubMed |
| 5 | 20,630,047 | Methicillin-resistant Staphylococcus aureus (MRSA) in three dairy herds in southwest Germany. | Zoonoses Public Health | 2011 | https://conductscience.org/library/papers/20630047 | PubMed |
| 6 | 25,015,717 | Assessment of synergistic combination potential of probiotic and bacteriophage against antibiotic-resistant Staphylococcus aureus exposed to simulated intestinal conditions. | Arch Microbiol | 2014 | https://conductscience.org/library/papers/25015717 | PubMed |
| 7 | 9,250,141 | Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. | Am J Clin Nutr | 1997 | https://conductscience.org/library/papers/9250141 | PubMed |
| 8 | 33,451,234 | Bacteriocins and their Food Applications. | Compr Rev Food Sci Food Saf | 2003 | https://conductscience.org/library/papers/33451234 | PubMed |
| 9 | 22,818,451 | Prevalence, antimicrobial resistance, and molecular characterization of methicillin-resistant Staphylococcus aureus from bulk tank milk of dairy herds. | J Dairy Sci | 2012 | https://conductscience.org/library/papers/22818451 | PubMed |
| 10 | 10,604,231 | Phage therapy: past history and future prospects. | Arch Immunol Ther Exp (Warsz) | 1999 | https://conductscience.org/library/papers/10604231 | PubMed |
| 11 | 18,024,129 | The genomics of lactic acid bacteria. | Trends Microbiol | 2007 | https://conductscience.org/library/papers/18024129 | PubMed |
| 12 | 15,090,528 | Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. | J Bacteriol | 2004 | https://conductscience.org/library/papers/15090528 | PubMed |
| 13 | 21,851,660 | Dry cow therapy with a non-antibiotic intramammary teat seal - a review. | Ir Vet J | 2004 | https://conductscience.org/library/papers/21851660 | PubMed |
| 14 | 15,728,933 | Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15728933 | PubMed |
| 15 | 10,714,861 | Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. | J Dairy Sci | 2000 | https://conductscience.org/library/papers/10714861 | PubMed |
| 16 | 17,517,843 | Experimental phage therapy against Staphylococcus aureus in mice. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17517843 | PubMed |
| 17 | 4,959,983 | Effect of lactic acid bacteria on growth of Staphylococcus aureus. | Appl Microbiol | 1966 | https://conductscience.org/library/papers/4959983 | PubMed |
| 18 | 30,862,020 | Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth. | Pharmaceuticals (Basel) | 2019 | https://conductscience.org/library/papers/30862020 | PubMed |
| 19 | 12,599,078 | Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. | J Infect Dis | 2003 | https://conductscience.org/library/papers/12599078 | PubMed |
| 20 | 15,476,976 | Rapid identification of probiotic Lactobacillus species by multiplex PCR using species-specific primers based on the region extending from 16S rRNA through 23S rRNA. | FEMS Microbiol Lett | 2004 | https://conductscience.org/library/papers/15476976 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,959,623 | Formulation, stability, and delivery of bacteriophage cocktails in veterinary medicine: a review of physicochemical constraints and therapeutic outcomes in production animals. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/42959623 | PubMed |
| 42,491,055 | Isolation, characterization, and in vitro efficacy of phage Citro-6 against Citrobacter freundii-induced bovine mastitis. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42491055 | PubMed |
| 42,434,394 | Phage Therapy for a Refractory and Multidrug-resistant Equine Surgical Site Infection. | Int J Vet Sci Med | 2026 | https://conductscience.org/library/papers/42434394 | PubMed |
| 41,750,478 | A Century-Old Solution for 21st Century Challenges: Current Applications with a Focus on Biocontrol, Environmental Impacts, and Regulatory Perspectives. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/41750478 | PubMed |
| 41,114,910 | Gut health management in livestock: roles of probiotics, prebiotics, and synbiotics in growth, immunity, and microbiota modulation. | Vet Res Commun | 2025 | https://conductscience.org/library/papers/41114910 | PubMed |
| 39,813,201 | A novel broad-spectrum bacteriophage cocktail against methicillin-resistant Staphylococcus aureus: Isolation, characterization, and therapeutic potential in a mastitis mouse model. | PLoS One | 2025 | https://conductscience.org/library/papers/39813201 | PubMed |
| 39,545,771 | Phage therapeutic delivery methods and clinical trials for combating clinically relevant pathogens. | Ther Deliv | 2025 | https://conductscience.org/library/papers/39545771 | PubMed |
| 38,666,970 | Bacteriophage Therapy in Companion and Farm Animals. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38666970 | PubMed |
| 38,357,445 | Bacteriophage therapy for drug-resistant Staphylococcus aureus infections. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/38357445 | PubMed |
| 37,627,727 | Bacteriophage Therapy to Control Bovine Mastitis: A Review. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37627727 | PubMed |
| 36,935,353 | The applications of animal models in phage therapy: An update. | Hum Vaccin Immunother | 2023 | https://conductscience.org/library/papers/36935353 | PubMed |
| 36,506,727 | Meloxicam in Combating Clinical Mastitis: Nanotechnology-Driven Hope and Opportunities. | J Pharm Bioallied Sci | 2022 | https://conductscience.org/library/papers/36506727 | PubMed |
| 36,422,325 | Immunomodulatory Effects of Probiotics: A Novel Preventive Approach for the Control of Bovine Mastitis. | Microorganisms | 2022 | https://conductscience.org/library/papers/36422325 | PubMed |
| 35,518,417 | Application of bacteriocins in food preservation and infectious disease treatment for humans and livestock: a review. | RSC Adv | 2020 | https://conductscience.org/library/papers/35518417 | PubMed |
| 35,335,222 | Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review. | Molecules | 2022 | https://conductscience.org/library/papers/35335222 | PubMed |
| 34,925,270 | Characteristics of a Bacteriophage, vB_Kox_ZX8, Isolated From Clinical Klebsiella oxytoca and Its Therapeutic Effect on Mice Bacteremia. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34925270 | PubMed |
| 34,064,754 | Phage Therapy in Livestock and Companion Animals. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34064754 | PubMed |
| 33,317,032 | Last Call for Replacement of Antimicrobials in Animal Production: Modern Challenges, Opportunities, and Potential Solutions. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/33317032 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32155751
GET https://conductscience.org/api/papers/v1/32155751/references?page=2